Trademark: 90356449
Word
PUMAS
Status
Registered
Status Code
700
Status Date
Tuesday, September 21, 2021
Serial Number
90356449
Registration Number
6490579
Registration Date
Tuesday, September 21, 2021
Mark Type
4000
Filing Date
Thursday, December 3, 2020
Published for Opposition
Tuesday, July 6, 2021

Trademark Owner History
Pumas-AI Inc. - Original Registrant

Classifications
9 downloadable computer software that uses artificial intelligence for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; downloadable computer software that uses artificial intelligence for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; software featuring machine learning and artificial intelligence for data analysis in the fields of data processing, analytics, information processing, data analysis, artificial intelligence, machine learning, deep learning, compound property prediction, compound structure prediction and data visualization in the fields of chemistry, pharmaceutical and agrochemical research and development; downloadable computer software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis for guiding experiment and study related decisions, namely, dose selection, patient selection, risk factor identification, endpoint selection, and for identifying genomic markers for efficacy and safety in support of regulatory submission to support product registration; downloadable computer artificial intelligence software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis; downloadable computer software for use in biological and chemical research, development, validation and testing in the life sciences field, including primarily the fields of biology, genomics, proteomics and pharmaceuticals for characterizing mechanism of action, understanding systems level biology and pharmacology, guide dose selection, and identify predictors for efficacy and safety; downloadable software platform using machine learning and artificial intelligence for training deep learning models on medical data and for use in medical predictions for use by healthcare organizations, life science and pharmaceutical companies to enhance precision in care quality, improve patient experience and advance new drugs and treatment methods, namely, building translational models, identifying patterns unknown to biology, augmenting systems biology models, enabling quality-by-design for pharmaceutical manufacturing, guiding treatment trajectory, precision dosing, individualized therapy, and extraction of signal from imaging data; downloadable bioinformatics software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable medical data monitoring, and applications that record, monitor, and analyze medical data, patient data, and provide patient diagnosis risk assessment for identifying trends related to patient treatment
35 providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences
42 research and development in the field of artificial intelligence software for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; scientific advisory services in the nature of computer modeling services, namely, computer simulation from computer programs for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; design and development of computer software for use in pharmaceutical research and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics; research and analysis services in the fields of biology, biotechnology, bioinformatics and in the pharmaceutical field; scientific research, namely, providing data analytics and data modelling to others in the fields of medical and pharmaceutical research and development; providing temporary use of web-based software featuring predictive analytics in the healthcare and life sciences industries; providing temporary use of web-based software for managing, accessing, analyzing, and sharing information and data in the healthcare and life sciences industries, namely, information and data in the fields of real world evidence

Trademark Events
Sep 21, 2021
Registered-Principal Register
Jul 6, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 6, 2021
Teas Change Of Correspondence Received
Jul 6, 2021
Teas Change Of Owner Address Received
Jul 6, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 6, 2021
Published For Opposition
Jun 16, 2021
Notification Of Notice Of Publication E-Mailed
Jun 3, 2021
Approved For Pub - Principal Register
Jun 2, 2021
Teas/Email Correspondence Entered
Jun 2, 2021
Correspondence Received In Law Office
Jun 2, 2021
Teas Response To Office Action Received
May 21, 2021
Notification Of Non-Final Action E-Mailed
May 21, 2021
Non-Final Action E-Mailed
May 21, 2021
Non-Final Action Written
May 21, 2021
Assigned To Examiner
Feb 8, 2021
New Application Office Supplied Data Entered
Dec 7, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24